NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy

CompletedNA

Sponsor: Rutgers, The State University of New Jersey

Conditions: Clinical Trials, Immunotherapy

Interventions: PINPOINT Digital Educational Tool

Countries: United States

The purpose of the research is to: develop an educational website to empower Black and African American cancer patients to make informed decisions about personalized cancer treatment and clinical trials. The sample size for the qualitative interviews was (n=48) when saturation was achieved. With a goal of (n=33) for the pilot trial, the overall target sample size for the study is (n=81).

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria

Patient Key Informant:

* Age 18 and older
* Self-identify as Black/African American
* Diagnosed with solid tumor
* Able to read and speak English fluently
* Able to provide informed consent
* Able to complete 1 survey and an in-depth interview

Relative Key Informant:

* Age 18 and older
* Spouse, blood relative, or caregiver of a cancer patient who identifies as Black/African American
* Able to read and speak English fluently
* Able to provide informed consent
* Able to complete 1 survey and an in-depth interview

Provider Key Informant:

* Age 18 and older
* Physician, nurse, social worker, patient navigator, or financial counselor
* Work in oncology setting
* Able to read and speak English fluently
* Able to provide informed consent
* Able to complete 1 survey and an in-depth interview

Pilot Tester:

* Age 18 and older
* Self-identify as Black/African American
* Able to read and speak English fluently
* Able to provide informed consent
* Newly diagnosed with solid tumor cancer (Stage I-IV)
* Have not yet consulted with an oncologist regarding treatment
* Able to complete 2 surveys and an in-depth interview

Exclusion Criteria

Key informants will be excluded from the study if they do not meet the inclusion criteria. Pilot testers will be excluded from the study if they previously participated as key informants and do not meet inclusion criteria.

Locations (1)

New Brunswick, New Jersey, United States